EFFECT OF IBANDRONATE ON RISKS FOR VERTEBRAL AND NONVERTEBRAL FRACTURES IN POSTMENOPAUSALOSTEOPOROSIS (A REVIEW OF CLINICAL TRIALS)
The paper presents data of a large number of clinical trials meeting the principles of evidence-based medicines, which have dealt with the evaluation of the efficacy of ibandronate in postmenopausal osteoporosis (OP). The administration of its registered formulations (150 mg weekly oral and 3 mg qua...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
IMA-PRESS LLC
2010-06-01
|
| Serie: | Современная ревматология |
| Soggetti: | |
| Accesso online: | http://mrj.ima-press.net/index.php/mrj/article/view/286 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|